In bile, the expression level of PRDX2 in HCC patients was markedly higher than that in choledocholithiasis patients (median level 9,395 vs. 4,858 ng/ml, p = 0.000) (Fig. 1B). The gene discussed is PRDX2; the disease is hepatocellular carcinoma.